"10.1371_journal.pone.0133591","plos one","2015-07-24T00:00:00Z","Pino Alonso; Daniel Cuadras; Loes Gabriëls; Damiaan Denys; Wayne Goodman; Ben D Greenberg; Fiacro Jimenez-Ponce; Jens Kuhn; Doris Lenartz; Luc Mallet; Bart Nuttin; Eva Real; Cinto Segalas; Rick Schuurman; Sophie Tezenas du Montcel; Jose M Menchon","OCD Clinical and Research Unit, Department of Psychiatry, Hospital de Bellvitge, Barcelona, Spain; Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain; CIBERSAM (Centro de Investigación en Red de Salud Mental), Carlos III Health Institute, Barcelona, Spain; Department of Clinical Sciences, Bellvitge Campus, University of Barcelona, Barcelona, Spain; Methodological and Statistical Assessment Unit, Parc Sanitari Sant Joan de Déu—Fundació Sant Joan de Déu, Barcelona, Spain; University Centre for OCD, Department of Psychiatry, UPC-KULeuven, Leuven, Belgium; Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Brain Imaging Center, Academic Medical Center, University of Amsterdam, and the Netherlands Institute for Neuroscience, Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands; Department of Psychiatry and Behavioral Health System, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Butler Hospital, Providence, Rhode Island, United States of America; Unit of Stereotactic, Functional Neurosurgery and Radiosurgery, General Hospital of Mexico, Mexico City, Mexico; Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany; UPMC-Inserm U1127-CNRS UMR7225, ICM–Brain & Spine Institute, Paris, France; Department of Neurosurgery, UZ Leuven, KU Leuven, Belgium; Department of Neurosurgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; UPMC Univ Paris 06, ER4, Modelling in Clinical Research, Paris, France; AP-HP, Hopitaux Universitaires Pitié-Salpétrière Charles-Foix, Department of Biostatistics and Medical Informatics, Paris, France","Conceived and designed the experiments: PA DC LG BDG LM JMM. Analyzed the data: PA DC LG LM ST JMM. Contributed reagents/materials/analysis tools: DD WG FJ JK DL BN ER CS RS. Wrote the paper: PA LG DD BDG JK LM BN JMM.","Pino Alonso, Cinto Segalas, Eva Real and José M. Menchón participate in a postmarket clinical follow-up study sponsored by Medtronic (Reclaim Deep Brain Stimulation Therapy for Obsessive-Compulsive Disorder: Post-Market Clinical Followup Study [OCD PMCF], registered on www.ClinicalTrials.gov, NCT01135745. José M.Menchón received grants for education and travel from Eli Lilly, Janssen, Lundbeck,Otsuka, Rovi and Servier. Loes Gabriëls is holder of the Chair for neurosurgery in psychiatric disorders at the KU Leuven, funded by Medtronic. Damiaan Denys and Rick Schuurman received unrestricted grants form Medtronic. Jens Kuhn and Doris Lenartz received financial support for IIT-DBS studies from Medtronic AG (Meerbusch, Germany). Luc Mallet received travel grants from Medtronic and consulting fees from AstraZeneca. Bart Nuttin received grants for research, education and travel from Cover Letter Medtronic. He owns a patent on DBS for OCD. He has a chair, 'stereotactic neurosurgery for psychiatric disorders', a donation from Medtronic. Daniel Cuadras, Wayne Goodman, Ben D. Greenberg, Fiacro Jiménez-Ponce and Sophie Tezenas du Montcel have declared that no competing interest exist. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","07","Pino Alonso","PA",16,FALSE,6,NA,6,8,TRUE,TRUE,FALSE,0,NA,FALSE
